rs4648018

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003998.4(NFKB1):​c.407+1908G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0409 in 152,146 control chromosomes in the GnomAD database, including 245 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.041 ( 245 hom., cov: 32)

Consequence

NFKB1
NM_003998.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.802

Publications

10 publications found
Variant links:
Genes affected
NFKB1 (HGNC:7794): (nuclear factor kappa B subunit 1) This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. NFKB is a critical regulator of the immediate-early response to viral infection. Alternative splicing results in multiple transcript variants encoding different isoforms, at least one of which is proteolytically processed. [provided by RefSeq, Aug 2020]
NFKB1 Gene-Disease associations (from GenCC):
  • immunodeficiency, common variable, 12
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • common variable immunodeficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.102 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003998.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NFKB1
NM_003998.4
MANE Select
c.407+1908G>C
intron
N/ANP_003989.2
NFKB1
NM_001382625.1
c.407+1908G>C
intron
N/ANP_001369554.1P19838-2
NFKB1
NM_001382626.1
c.407+1908G>C
intron
N/ANP_001369555.1P19838-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NFKB1
ENST00000226574.9
TSL:1 MANE Select
c.407+1908G>C
intron
N/AENSP00000226574.4P19838-2
NFKB1
ENST00000394820.8
TSL:1
c.404+1908G>C
intron
N/AENSP00000378297.4P19838-1
NFKB1
ENST00000505458.5
TSL:1
c.404+1908G>C
intron
N/AENSP00000424790.1P19838-1

Frequencies

GnomAD3 genomes
AF:
0.0409
AC:
6213
AN:
152030
Hom.:
244
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.104
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0204
Gnomad ASJ
AF:
0.0101
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00373
Gnomad FIN
AF:
0.0152
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0192
Gnomad OTH
AF:
0.0278
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0409
AC:
6220
AN:
152146
Hom.:
245
Cov.:
32
AF XY:
0.0391
AC XY:
2905
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.104
AC:
4332
AN:
41512
American (AMR)
AF:
0.0202
AC:
309
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.0101
AC:
35
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.00394
AC:
19
AN:
4824
European-Finnish (FIN)
AF:
0.0152
AC:
161
AN:
10598
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0192
AC:
1303
AN:
67954
Other (OTH)
AF:
0.0275
AC:
58
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
293
586
879
1172
1465
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0353
Hom.:
12
Bravo
AF:
0.0433
Asia WGS
AF:
0.00953
AC:
35
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.10
DANN
Benign
0.49
PhyloP100
-0.80
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4648018; hg19: chr4-103490200; API